C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: A placebo-controlled randomized study

European Journal of Nutrition

Volumn 46, Issue 7, 2007, Pages 428-430

  Madsen, Trine ^a   Christensen, Jeppe H ^a   Schmidt, Erik B ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

C reactive protein; Coronary heart disease; Fish oil; Inflammation; n 3 fatty acids

Indexed keywords

C REACTIVE PROTEIN; FISH OIL; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART INFARCTION; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE;

AGED; BLOOD PLATELETS; C-REACTIVE PROTEIN; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PLANT OILS; TREATMENT OUTCOME;

EID: 37249064696     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-007-0673-8     Document Type: Article

References (14)

1. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2:757-761
2. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K, Dyerberg J, Schmidt EB (1996) Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 312:677-678
3. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999) Lancet 354:447-455
4. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91:439-446
5. Grundt H, Nilsen DW, Mansoor MA, Hetland O, Nordoy A (2003) Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33:88-95
6. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB (2004) Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134:1806-1811
7. Madsen T, Christensen JH, Blom M, Schmidt EB (2003) The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 89:517-522
8. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, Schmidt EB (2001) C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88:1139-1142
9. Mori TA, Beilin LJ (2004) Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6:461-467
10. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ (2003) Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35:772-781
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
12. Prasad K (2006) C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 24:33-50
13. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
14. Schmidt EB, Pedersen JO, Varming K, Ernst E, Jersild C, Grunnet N, Dyerberg J (1991) n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arterioscler Thromb 11:429-435